Cargando…
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234811/ https://www.ncbi.nlm.nih.gov/pubmed/28085948 http://dx.doi.org/10.1371/journal.pone.0170539 |
| _version_ | 1782495055663071232 |
|---|---|
| author | Kawano, Satoshi Grassian, Alexandra R. Tsuda, Masumi Knutson, Sarah K. Warholic, Natalie M. Kuznetsov, Galina Xu, Shanqin Xiao, Yonghong Pollock, Roy M. Smith, Jesse J. Kuntz, Kevin W. Ribich, Scott Minoshima, Yukinori Matsui, Junji Copeland, Robert A. Tanaka, Shinya Keilhack, Heike |
| author_facet | Kawano, Satoshi Grassian, Alexandra R. Tsuda, Masumi Knutson, Sarah K. Warholic, Natalie M. Kuznetsov, Galina Xu, Shanqin Xiao, Yonghong Pollock, Roy M. Smith, Jesse J. Kuntz, Kevin W. Ribich, Scott Minoshima, Yukinori Matsui, Junji Copeland, Robert A. Tanaka, Shinya Keilhack, Heike |
| author_sort | Kawano, Satoshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5234811 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52348112017-02-06 Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma Kawano, Satoshi Grassian, Alexandra R. Tsuda, Masumi Knutson, Sarah K. Warholic, Natalie M. Kuznetsov, Galina Xu, Shanqin Xiao, Yonghong Pollock, Roy M. Smith, Jesse J. Kuntz, Kevin W. Ribich, Scott Minoshima, Yukinori Matsui, Junji Copeland, Robert A. Tanaka, Shinya Keilhack, Heike PLoS One Correction Public Library of Science 2017-01-13 /pmc/articles/PMC5234811/ /pubmed/28085948 http://dx.doi.org/10.1371/journal.pone.0170539 Text en © 2017 Kawano et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Kawano, Satoshi Grassian, Alexandra R. Tsuda, Masumi Knutson, Sarah K. Warholic, Natalie M. Kuznetsov, Galina Xu, Shanqin Xiao, Yonghong Pollock, Roy M. Smith, Jesse J. Kuntz, Kevin W. Ribich, Scott Minoshima, Yukinori Matsui, Junji Copeland, Robert A. Tanaka, Shinya Keilhack, Heike Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title | Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title_full | Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title_fullStr | Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title_full_unstemmed | Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title_short | Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma |
| title_sort | correction: preclinical evidence of anti-tumor activity induced by ezh2 inhibition in human models of synovial sarcoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234811/ https://www.ncbi.nlm.nih.gov/pubmed/28085948 http://dx.doi.org/10.1371/journal.pone.0170539 |
| work_keys_str_mv | AT kawanosatoshi correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT grassianalexandrar correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT tsudamasumi correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT knutsonsarahk correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT warholicnataliem correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT kuznetsovgalina correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT xushanqin correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT xiaoyonghong correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT pollockroym correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT smithjessej correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT kuntzkevinw correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT ribichscott correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT minoshimayukinori correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT matsuijunji correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT copelandroberta correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT tanakashinya correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma AT keilhackheike correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma |